The zinc finger transcription factor ZFX Is required for maintaining the tumorigenic potential of glioblastoma stem cells

Stem Cells

Volumn 32, Issue 8, 2014, Pages 2033-2047

  Fang, Xiaoguang ^a   Huang, Zhi ^a   Zhou, Wenchao ^a   Wu, Qiulian ^a   Sloan, Andrew E ^c   Ouyang, Gaoliang ^d   McLendon, Roger E ^e   Yu, Jennifer S ^a,b   Rich, Jeremy N ^a   Bao, Shideng ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d XIAMEN UNIVERSITY   (China)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

c Myc; Cancer stem cell; Glioblastoma; Self renewal; Tumorigenesis; Zinc finger and X linked transcription factor

Indexed keywords

SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ZFX; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; ZINC FINGER PROTEIN, X-LINKED;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER STEM CELL; CARCINOGENIC ACTIVITY; CELL RENEWAL; CONTROLLED STUDY; GENE SEQUENCE; GLIOBLASTOMA; GLIOMA CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NEURAL STEM CELL; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR GROWTH; UPREGULATION; CELL CULTURE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUNEL ASSAY;

CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; FLUORESCENT ANTIBODY TECHNIQUE; GLIOBLASTOMA; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NEOPLASTIC STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84904409295     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1730     Document Type: Article

References (56)

1. Furnari FB, Fenton T, Bachoo RM, et al. Malignant astrocytic glioma: Genetics, biology, and paths to treatment. Genes Dev 2007; 21: 2683-2710.
2. Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009; 10: 459-466.
3. Wen PY, Kesari S,. Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507.
4. Bonavia R, Inda MM, Cavenee WK, et al. Heterogeneity maintenance in glioblastoma: A social network. Cancer Res 2011; 71: 4055-4060.
5. Magee JA, Piskounova E, Morrison SJ,. Cancer stem cells: Impact, heterogeneity, and uncertainty. Cancer Cell 2012; 21: 283-296.
6. Venere M, Fine HA, Dirks PB, et al. Cancer stem cells in gliomas: Identifying and understanding the apex cell in cancer's hierarchy. Glia 2011; 59: 1148-1154.
7. Vescovi AL, Galli R, Reynolds BA,. Brain tumour stem cells. Nat Rev Cancer 2006; 6: 425-436.
8. Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444: 756-760.
9. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-7021.
10. Hemmati HD, Nakano I, Lazareff JA, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003; 100: 15178-15183.
11. Ignatova TN, Kukekov VG, Laywell ED, et al. Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 2002; 39: 193-206.
12. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
13. Piccirillo SG, Reynolds BA, Zanetti N, et al. Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 2006; 444: 761-765.
14. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
15. Bao S, Wu Q, Sathornsumetee S, et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006; 66: 7843-7848.
16. Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell 2007; 11: 69-82.
17. Gilbertson RJ, Rich JN,. Making a tumour's bed: Glioblastoma stem cells and the vascular niche. Nat Rev Cancer 2007; 7: 733-736.
18. Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
19. Wei J, Barr J, Kong LY, et al. Glioma-associated cancer-initiating cells induce immunosuppression. Clin Cancer Res 2010; 16: 461-473.
20. Cheng L, Huang Z, Zhou W, et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 2013; 153: 139-152.
21. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
22. Kim J, Orkin SH,. Embryonic stem cell-specific signatures in cancer: Insights into genomic regulatory networks and implications for medicine. Genome Med 2011; 3: 75.
23. Kim J, Woo AJ, Chu J, et al. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010; 143: 313-324.
24. Zheng H, Ying H, Yan H, et al. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008; 455: 1129-1133.
25. Chen X, Xu H, Yuan P, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008; 133: 1106-1117.
26. Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008; 132: 1049-1061.
27. Dang CV,. MYC on the path to cancer. Cell 2012; 149: 22-35.
28. Nilsson JA, Cleveland JL,. Myc pathways provoking cell suicide and cancer. Oncogene 2003; 22: 9007-9021.
29. King B, Trimarchi T, Reavie L, et al. The ubiquitin ligase FBXW7 modulates leukemia-initiating cell activity by regulating MYC stability. Cell 2013; 153: 1552-1566.
30. Wang J, Wang H, Li Z, et al. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One 2008; 3: e3769.
31. Galan-Caridad JM, Harel S, Arenzana TL, et al. Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell 2007; 129: 345-357.
32. Harel S, Tu EY, Weisberg S, et al. ZFX controls the self-renewal of human embryonic stem cells. PLoS One 2012; 7: e42302.
33. Young RA,. Control of the embryonic stem cell state. Cell 2011; 144: 940-954.
34. Hu G, Kim J, Xu Q, et al. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 2009; 23: 837-848.
35. Ouyang Z, Zhou Q, Wong WH,. ChIP-Seq of transcription factors predicts absolute and differential gene expression in embryonic stem cells. Proc Natl Acad Sci USA 2009; 106: 21521-21526.
36. North M, Sargent C, O'Brien J, et al. Comparison of ZFY and ZFX gene structure and analysis of alternative 3' untranslated regions of ZFY. Nucleic Acids Res 1991; 19: 2579-2586.
37. Teif VB, Vainshtein Y, Caudron-Herger M, et al. Genome-wide nucleosome positioning during embryonic stem cell development. Nat Struct Mol Biol 2012; 19: 1185-1192.
38. Gokhman D, Livyatan I, Sailaja BS, et al. Multilayered chromatin analysis reveals E2f, Smad and Zfx as transcriptional regulators of histones. Nat Struct Mol Biol 2013; 20: 119-126.
39. O'Donnell KA, Keng VW, York B, et al. A Sleeping Beauty mutagenesis screen reveals a tumor suppressor role for Ncoa2/Src-2 in liver cancer. Proc Natl Acad Sci USA 2012; 109: E1377-E1386.
40. Zhou Y, Su Z, Huang Y, et al. The Zfx gene is expressed in human gliomas and is important in the proliferation and apoptosis of the human malignant glioma cell line U251. J Exp Clin Cancer Res 2011; 30: 114.
41. Zhu Z, Li K, Xu D, et al. ZFX regulates glioma cell proliferation and survival in vitro and in vivo. J Neurooncol 2013; 112: 17-25.
42. Li Z, Bao S, Wu Q, et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009; 15: 501-513.
43. Guryanova OA, Wu Q, Cheng L, et al. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011; 19: 498-511.
44. Huang Z, Wu Q, Guryanova OA, et al. Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells. Nat Cell Biol 2011; 13: 142-152.
45. Hjelmeland AB, Lathia JD, Sathornsumetee S, et al. Twisted tango: Brain tumor neurovascular interactions. Nat Neurosci 2011; 14: 1375-1381.
46. Bao S, Wu Q, Li Z, et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008; 68: 6043-6048.
47. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-1512.
48. L'Haridon M, Paul P, Xerri JG, et al. Transcriptional regulation of the MHC class I HLA-A11 promoter by the zinc finger protein ZFX. Nucleic Acids Res 1996; 24: 1928-1935.
49. Luoh SW, Bain PA, Polakiewicz RD, et al. Zfx mutation results in small animal size and reduced germ cell number in male and female mice. Development 1997; 124: 2275-2284.
50. Vita M, Henriksson M,. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol 2006; 16: 318-330.
51. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
52. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
53. Radke J, Bortolussi G, Pagenstecher A,. Akt and c-Myc induce stem-cell markers in mature primary p53(-)/(-) astrocytes and render these cells gliomagenic in the brain of immunocompetent mice. PLoS One 2013; 8: e56691.
54. Weisberg SP, Smith-Raska MR, Esquilin JM, et al. ZFX controls propagation and prevents differentiation of acute T-lymphoblastic and myeloid leukemia. Cell Rep 2014; 6: 528-540.
55. Gordan JD, Bertout JA, Hu CJ, et al. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 2007; 11: 335-347.
56. Gordan JD, Thompson CB, Simon MC,. HIF and c-Myc: Sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 2007; 12: 108-113.